Venet Amelie, Vergier Romain, Cenac Kurlene, Inamo Jocelyn, Müssigbrodt Andreas
Department of Cardiology CHU Martinique (University Hospital of Martinique) Fort de France Martinique.
Department of Cardiology Tapion Hospital and OKEU Hospital Castries Saint Lucia.
Clin Case Rep. 2024 Aug 12;12(8):e9309. doi: 10.1002/ccr3.9309. eCollection 2024 Aug.
Venous spasm is an important reason for complicated or failed implantations of cardiac implantable electronic devices. Prevention or risk reduction of venous spasm during cardiac implantable electronic device implantation may be achieved by ultrasound or fluoroscopic imaging prior to puncture, cephalic vein cut-down, sufficient pre- and perioperative hydration, nitroglycerin injection and effective sedation, and analgesia.
This case report with literature review focuses on venous spasm as a potential cause for complicated implantations of cardiac implantable electronic devices. The case report is clinically relevant as it describes a progressive spasm affecting the axillary and the subclavian vein. A 66-year-old female complained of symptomatic atrial fibrillation (AF) and atypical atrial flutter despite interventional and medical treatment. As an ultimate treatment, she was scheduled for pacemaker implantation and atrioventricular node ablation. Several puncture attempts of the axillary vein failed. Despite venous blood aspiration, no guidewires could be advanced into the axillary vein. We performed a first venogram revealing significant spasm of the axillary vein. Another failed venous puncture occurred after change of access site to the subclavian vein. A second venogram displayed progression of the spasm, now affecting both the axillary and the subclavian veins. Normal saline perfusion was administered as well as intravenous isosorbide. Unfortunately, a repeated venogram after 15 min waiting time showed persistence of the spasm, still affecting both veins. The procedure was discontinued as the patient became uncomfortable. Venous spasm is an important reason for complicated or failed implantations of cardiac implantable electronic devices. Commonly used medical prevention and treatment are intravenous fluids and nitroglycerin. Prevention or risk reduction of venous spasm during cardiac implantable electronic device implantation may be achieved by ultrasound or fluoroscopic imaging prior to puncture, cephalic vein cut-down, sufficient pre- and perioperative hydration, nitroglycerin injection and effective sedation and analgesia.
静脉痉挛是心脏植入式电子设备植入复杂或失败的重要原因。在心脏植入式电子设备植入过程中,可通过穿刺前超声或透视成像、头静脉切开、充分的术前和围手术期补液、硝酸甘油注射以及有效的镇静和镇痛来预防或降低静脉痉挛风险。
本病例报告并文献复习聚焦于静脉痉挛作为心脏植入式电子设备植入复杂情况的潜在原因。该病例报告具有临床相关性,因为它描述了一种影响腋静脉和锁骨下静脉的进行性痉挛。一名66岁女性尽管接受了介入和药物治疗,但仍有症状性心房颤动(AF)和非典型心房扑动。作为最终治疗,她计划接受起搏器植入和房室结消融。多次尝试穿刺腋静脉均失败。尽管抽出了静脉血,但导丝无法推进到腋静脉。我们进行了首次静脉造影,显示腋静脉有明显痉挛。更换穿刺部位至锁骨下静脉后,再次静脉穿刺失败。第二次静脉造影显示痉挛进展,此时腋静脉和锁骨下静脉均受影响。给予生理盐水灌注和静脉注射异山梨醇。不幸的是,等待15分钟后重复静脉造影显示痉挛持续存在,两条静脉仍受影响。由于患者感到不适,手术中断。静脉痉挛是心脏植入式电子设备植入复杂或失败的重要原因。常用的医学预防和治疗方法是静脉输液和硝酸甘油。在心脏植入式电子设备植入过程中,可通过穿刺前超声或透视成像、头静脉切开、充分的术前和围手术期补液、硝酸甘油注射以及有效的镇静和镇痛来预防或降低静脉痉挛风险。